Schematic approach for the management of myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia.
Key- MDS-RS- myelodysplastic syndrome with ring sideroblasts, EPO- erythropoietin, rH- recombinant human, G-CSF- granulocyte colony stimulating factor, ESA- erythropoiesis stimulating agents.
* Immunosuppressive therapy could be considered in individuals with hypoplastic bone marrows and a HLA-DR-15 phenotype.